Sartorius has collaborated with ElevateBio, a cell therapy CDMO, among other partners, to test the Eveo platform.
Pharmaceutical companies are shifting from the development of autologous cell therapies to allogeneic cell therapies.
Pharmaceutical Technology on MSN
Quintessence debuts first ‘living’ artificial cell for CGT bio-separation
The technology is designed to simplify the bio-separation process while reducing manufacturing costs.
Intermediate-scale benchtop bioreactor protocol streamlines production of iPSC-derived macrophages for research, drug discovery, and modeling.
The "Cell and Gene Therapy Manufacturing Market -- Growth, Share, Opportunities & Competitive Analysis, 2024 -- 2032" report has been added to the Credence Research Inc. offering. The global Cell and ...
Zacks Investment Research on MSN
IBRX stock jumps on progress in NK cell therapy production
Shares of ImmunityBio IBRX rose more than 7% on Friday after the company announced that it completed two manufacturing ...
The company is establishing commercial production capabilities to fuel plans to launch autologous CAR-T cell therapies in China.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results